Screener
XBI vs KRE
State Street SPDR S&P Biotech ETF vs State Street SPDR S&P Regional Banking ETF
Key differences
- Over the last 3 years, KRE has delivered higher annualized returns.
Side-by-side comparison
| XBI | KRE | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $8.3B | $4.2B |
| Since | 2006 | 2006 |
| Dividend yield | 0.34% | 2.25% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +70.7% | +26.5% |
| CAGR 3Y | +16.6% | +24.7% |
| CAGR 5Y | +1.6% | +2.7% |
| Sharpe 3Y | 0.57 | 0.79 |
| Volatility 1Y | 25.16% | 23.30% |
| Max drawdown | -63.89% | -55.03% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XBI and KRE
Explore further